Mar­ket­ingRx roundup: Ar­cutis joins crowd­ed pso­ri­a­sis ad mar­ket on TV; Mer­ck, GSK, Mod­er­na high­light im­mu­niza­tion month

Ar­cutis is jump­ing in­to the pso­ri­a­sis TV ad mar­ket with its first-ever com­mer­cial for Zorvye, its non-steroid cream ap­proved in Ju­ly 2022. The mes­sage be­hind the ad called “The Cream That Can” is about mak­ing the top­i­cal man­age­ment of plaque pso­ri­a­sis sim­ple, the com­pa­ny said in a press re­lease.

The ad will air on lead­ing on-de­mand stream­ing ser­vices, aim­ing to reach many of the now more than 130 mil­lion com­mer­cial pa­tients who have ac­cess to Zo­ryve (rof­lu­mi­last), the bio­phar­ma said.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.